| Oncolytic group B adenovirus enadenotucirev mediates non-apoptotic cell death with membrane disruption and release of inflammatory mediators A Dyer, Y Di, H Calderon, S Illingworth, G Kueberuwa, A Tedcastle, ... Molecular Therapy-Oncolytics 4, 18-30, 2017 | 52 | 2017 |
| Newcastle disease virus strain AF2240 as an oncolytic virus: A review J Kalyanasundram, A Hamid, K Yusoff, SL Chia Acta tropica 183, 126-133, 2018 | 41 | 2018 |
| Evaluation of a recombinant Newcastle disease virus expressing human IL12 against human breast cancer Z Mohamed Amin, MA Che Ani, SW Tan, SK Yeap, NB Alitheen, ... Scientific Reports 9 (1), 13999, 2019 | 38 | 2019 |
| Viral persistence in colorectal cancer cells infected by Newcastle disease virus SL Chia, K Yusoff, N Shafee Virology journal 11, 1-8, 2014 | 28 | 2014 |
| Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to … SL Chia, J Lei, DJP Ferguson, A Dyer, KD Fisher, LW Seymour Virology 505, 162-171, 2017 | 26 | 2017 |
| Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference A Dyer, R Baugh, SL Chia, S Frost, Iris, EJ Jacobus, H Khalique, ... Cancer gene therapy 26 (3), 59-73, 2019 | 25 | 2019 |
| Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis J Kalyanasundram, SL Chia, AAL Song, AR Raha, HA Young, K Yusoff BMC biotechnology 15, 1-10, 2015 | 24 | 2015 |
| Synthesis and optimization of mesoporous silica nanoparticles for ruthenium polypyridyl drug delivery SN Harun, H Ahmad, HN Lim, SL Chia, MR Gill Pharmaceutics 13 (2), 150, 2021 | 23 | 2021 |
| Metallointercalator [Ru(dppz)2(PIP)]2+ Renders BRCA Wild-Type Triple-Negative Breast Cancer Cells Hypersensitive to PARP Inhibition NA Yusoh, SW Leong, SL Chia, SN Harun, MBA Rahman, KA Vallis, ... ACS chemical biology 15 (2), 378-387, 2020 | 17 | 2020 |
| Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice SUFS Najmuddin, ZM Amin, SW Tan, SK Yeap, J Kalyanasundram, ... PeerJ 8, e9761, 2020 | 16 | 2020 |
| Plaque formation by a velogenic Newcastle disease virus in human colorectal cancer cell lines SL Chia, WS Tan, K Yusoff, N Shafee Acta Virol 56 (4), 345-347, 2012 | 16 | 2012 |
| Structural analysis of peptides that interact with Newcastle disease virus SL Chia, WS Tan, K Shaari, NA Rahman, K Yusoff, SD Satyanarayanajois Peptides 27 (6), 1217-1225, 2006 | 15 | 2006 |
| In-vitro and in-silico evaluations of heterocyclic-containing diarylpentanoids as Bcl-2 inhibitors against LoVo colorectal cancer cells SW Leong, SL Chia, F Abas, K Yusoff Molecules 25 (17), 3877, 2020 | 11 | 2020 |
| Assessment of non-biting synanthropic flies associated with fresh markets WHL FN Khoso, SK Wong, SL Chia Journal of Entomology and Zoology Studies 3 (1), 13-20, 2015 | 11 | 2015 |
| Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo SUFS Najmuddin, ZM Amin, SW Tan, SK Yeap, J Kalyanasundram, ... Cancer Cell International 20, 1-18, 2020 | 10 | 2020 |
| Synthesis and in vitro biological evaluations of novel tetrapeptide as therapeutic agent for wound treatment NIM Fadilah, H Ahmad, MBA Rahman, SL Chia, SF Ng, SW Leong Journal of Saudi chemical society 24 (8), 606-619, 2020 | 10 | 2020 |
| Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes LC Chan, J Kalyanasundram, SW Leong, MJ Masarudin, ... BMC cancer 21 (1), 625, 2021 | 9 | 2021 |
| Virotherapy: current trends and future prospects for treatment of colon and rectal malignancies CL Lee, S Veeramani, A Molouki, SHE Lim, W Thomas, SL Chia, K Yusoff Cancer Investigation 37 (8), 393-414, 2019 | 9 | 2019 |
| Asymmetrical meta-methoxylated diarylpentanoids: Rational design, synthesis and anti-cancer evaluation in-vitro SW Leong, SL Chia, F Abas, K Yusoff European Journal of Medicinal Chemistry 157, 716-728, 2018 | 9 | 2018 |
| Synergy of ruthenium metallo-intercalator, [Ru(dppz)2(PIP)]2+, with PARP inhibitor Olaparib in non-small cell lung cancer cells NA Yusoh, SL Chia, N Saad, H Ahmad, MR Gill Scientific Reports 13 (1), 1456, 2023 | 7 | 2023 |
